VRNA - Verona Pharma Plc
This page shows which of the focused investors we track hold VRNA and how their positions changed, so you can see how much conviction the group has in the stock.
In Q2 2025 it was held by 2 managers with an aggregate reported value of $144.13M, which is 0.01% of the combined portfolio.
As of Q2 2025, 2 tracked institutional managers held VRNA (Verona Pharma Plc) with an aggregate reported value of $144.13M — 0.01% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades VRNA — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q2 2025
- Ticker
- VRNA
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Stanley Druckenmiller - Duquesne Family Office LLC | 2.42% | - | 1,002,080 | $94.78M |
| 2 | Lee Ainslie - Maverick Capital | 0.76% | Reduce -70.7% | 521,859 | $49.36M |
Loading holder history for VRNA…